In this seminar you will meet three speakers from SwissPedNet, the Swiss Research Network of Clinical Pediatric Hubs. Based on their individual expertise, they will share different challenges of paediatric HRO research projects and how they can be proactively managed.

Artificial intelligence is transforming clinical research, but with great opportunity comes great complexity. How do we harness AI’s potential while navigating the regulatory, ethical, and legal challenges it brings?

The Swiss National Science Foundation (SNSF) has launched the 12th call of its Investigator-Initiated Clinical Trials (IICT) programme for clinical studies on topics that are outside the industry focus.

This year’s International Clinical Trials Day (ICTD) will be held on Wednesday 20 May, 2026 in Prague, Czech Republi on the topic Stronger Together: Advanced Therapy Clinical Trials Without Borders.

We are pleased to announce that Switzerland is now fully available in ECRIN’s Regulatory & Ethical Database (RED), further expanding access to essential regulatory and ethical information for clinical research in Europe and beyond.

We are delighted to invite you to the 6th D|A|CH Symposium on Clinical Trials, taking place on 29–30 September 2026 at the Congress Innsbruck, Austria.

16 February 2026 marked a significant milestone in European Clinical Research Infrastructure Network (ECRIN) -ERIC’s history: For the first time in over a decade, the Assembly of Members (AoM) convened under new leadership. The meeting formally transitioned the chairship away from Rafael De Andrés Medina, who has guided the governing body for twelve years, and welcomed two new figures to steer ECRIN’s future direction.

In this podcast, Daniel Hammes from DKF Basel speaks with Christina Huf, ECRIN Correspondent and member of the SCTO Executive Office, about how Swiss researchers can successfully conduct multinational clinical trials.

The national Coordination Platform Clinical Research (CPCR) has launched the CPCR Service Finder, a new collaborative tool developed jointly by Swiss Biobanking (technical lead), the Swiss Cancer Institute, the Swiss Clinical Trial Organisation (SCTO), the Swiss Personalized Health Network (SPHN), with the support and coordination of the Swiss Academy of Medical Sciences (SAMS).